This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | |||
| contacts:croce:full_cv [2026/06/04 16:52] – [Current responsibilities and institutional activities] olivier | contacts:croce:full_cv [2026/06/30 09:22] (current) – [Selected publications] olivier | ||
|---|---|---|---|
| Line 252: | Line 252: | ||
| - | ===== Selected | + | ===== Recent |
| A complete publication list is available here: [[contacts: | A complete publication list is available here: [[contacts: | ||
| + | * Kellermann G, et al. 2026. Comprehensive mapping of identical sequences across human proteins emphasizes the widespread issue of shared epitopes in self-antigens. //NAR Genom Bioinform// | ||
| * Chevalier A. et al. 2026. Genomic determinants of //Bacillus cereus// and outcomes of infection in preterm neonates: a multicentre retrospective study. //Clinical Microbiology and Infection// | * Chevalier A. et al. 2026. Genomic determinants of //Bacillus cereus// and outcomes of infection in preterm neonates: a multicentre retrospective study. //Clinical Microbiology and Infection// | ||
| * Andreoni-Pham R. et al. 2025. Whole body regeneration deploys a rewired embryonic gene regulatory network logic. //Nature Communications// | * Andreoni-Pham R. et al. 2025. Whole body regeneration deploys a rewired embryonic gene regulatory network logic. //Nature Communications// | ||
| Line 263: | Line 264: | ||
| * Ben Khedher M. et al. 2022. Application and challenge of third-generation sequencing for clinical bacterial studies. // | * Ben Khedher M. et al. 2022. Application and challenge of third-generation sequencing for clinical bacterial studies. // | ||
| * Robin J.D. et al. 2020. Mitochondrial function in skeletal myofibers is controlled by a TRF2-SIRT3 axis over lifetime. //Aging Cell//. | * Robin J.D. et al. 2020. Mitochondrial function in skeletal myofibers is controlled by a TRF2-SIRT3 axis over lifetime. //Aging Cell//. | ||
| - | * Cherfils-Vicini J. et al. 2019. Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2. //EMBO Journal//. | ||
| See also: [[contacts: | See also: [[contacts: | ||